951
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Menstrual pattern in polycystic ovary syndrome and hypothalamic-pituitary-ovarian axis immaturity in adolescents: a systematic review and meta-analysis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2360077 | Received 04 Dec 2023, Accepted 21 May 2024, Published online: 31 May 2024

References

  • Elmaoğulları S, Aycan Z. Abnormal uterine bleeding in adolescents. J Clin Res Pediatr Endocrinol. 2018;10(3):191–197. doi: 10.4274/jcrpe.0014.
  • Benetti-Pinto CL, De Sá Rosa-E-Silva ACJ, Yela DA, et al. Abnormal Uterine Bleeding. Rev Bras Ginecol e Obstet. 2017;39(7):358–368.
  • Lemarchand-Béraud T, Zufferey MM, Reymond M, et al. Maturation of the hypothalamo-pituitary-ovarian axis in adolescent girls. J Clin Endocrinol Metab. 1982;54(2):241–246. doi: 10.1210/jcem-54-2-241.
  • Polis RL, Hertweck SP. Treatment options for the adolescent patient experiencing abnormal uterine bleeding. Curr Treat Options Pediatr. 2016;2(3):184–195.
  • Arao Y, Hamilton KJ, Wu SP, et al. Dysregulation of hypothalamic-pituitary estrogen receptor α-mediated signaling causes episodic LH secretion and cystic ovary. Faseb J. 2019;33(6):7375–7386. doi: 10.1096/fj.201802653RR.
  • Cardoso CBMA, Bordallo MAN. Distúrbios menstruais na adolescência. Adolescência Saude. 2004;1(4):23–25.
  • Sun BZ, Kangarloo T, Adams JM, et al. Healthy post-menarchal adolescent girls demonstrate multi-level reproductive axis immaturity. J Clin Endocrinol Metab. 2019;104(2):613–623. doi: 10.1210/jc.2018-00595.
  • Spritzer PM, Motta AB. Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment. Int J Clin Pract. 2015;69(11):1236–1246. doi: 10.1111/ijcp.12719.
  • Adone A, Fulmali DG. Polycystic ovarian syndrome in adolescents. Cureus. 2023;15(1):e34183. doi: 10.7759/cureus.34183.
  • Khan L. Polycystic ovarian syndrome in adolescents: keys to diagnosis and management. Pediatr Ann. 2021;50(7):e272–e275. doi: 10.3928/19382359-20210622-01.
  • March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544–551.
  • Rosenfield RL. The diagnosis of polycystic ovary syndrome in adolescents. Pediatrics. 2015;136(6):1154–1165. doi: 10.1542/peds.2015-1430.
  • Teede HJ, Tay CT, Laven J, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023;120(4):767–793.
  • Fauser BCJM, Tarlatzis BC, RWz R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS consensus workshop group. Fertil Steril. 2012;97(1):28–38.e25.
  • WHO, World Health Organization. Young people’s health – a challenge for society. Report of a WHO study group on young people and health for all. Technical Report Series 731. Geneva: WHO, 1986.
  • Escobar-Morreale HF, Roldán B, Barrio R, et al. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab. 2000;85(11):4182–4187. doi: 10.1210/jc.85.11.4182.
  • Codner E, Soto N, Lopez P, et al. Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J Clin Endocrinol Metab. 2006;91(6):2250–2256. doi: 10.1210/jc.2006-0108.
  • Samara-Boustani D, Colmenares A, Elie C, et al. High prevalence of hirsutism and menstrual disorders in obese adolescent girls and adolescent girls with type 1 diabetes mellitus despite different hormonal profiles. Eur J Endocrinol. 2012;166(2):307–316. doi: 10.1530/EJE-11-0670.
  • Escobar-Morreale HF, Roldan-Martin MB. Type 1 diabetes and polycystic ovary syndrome: systematic review and meta-analysis. Diabetes Care. 2016;39(4):639–648. doi: 10.2337/dc15-2577.
  • Baillargeon JP, Nestler JE. Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab. 2006;91(1):22–24. doi: 10.1210/jc.2005-1804.
  • Janssen OE, Mehlmauer N, Hahn S, et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol. 2004;150(3):363–369. doi: 10.1530/eje.0.1500363.
  • Petríková J, Lazúrová I, Yehuda S. Polycystic ovary syndrome and autoimmunity. Eur J Intern Med. 2010;21(5):369–371. doi: 10.1016/j.ejim.2010.06.008.
  • Nisar S, Shah PA, Kuchay MS, et al. Association of polycystic ovary syndrome and grave’s disease: is autoimmunity the link between the two diseases. Indian J Endocr Metab. 2012;16(2):982–986.
  • Baracat EC, Soares JM. Ovários policísticos, resistência insulínica e síndrome metabólica. Rev Bras Ginecol e Obstet. 2007;29(3):117–119.
  • Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–4592.
  • Arie WMY, Fonseca AM, Bagmoli VR, et al. Polycystic ovary syndrome and metformin: evidence-based review. Femina. 2009;37(11):585–602.
  • Hermont AP, Oliveira PAD, Martins CC, et al. Tooth erosion and eating disorders: a systematic review and meta-analysis. PLoS One. 2014;9(11):e111123. doi: 10.1371/journal.pone.0111123.
  • Wells GA, Shea B, O’Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses. 2014. Available online at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  • Ybarra M, Franco RR, Cominato L, et al. Polycystic ovary syndrome among obese adolescents. Gynecol Endocrinol. 2018;34(1):45–48. doi: 10.1080/09513590.2017.1359250.
  • Witchel SF, Oberfield S, Rosenfield RL, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015;83(6):376–389. doi: 10.1159/000375530.
  • Kaewnin J, Vallibhakara O, Arj-Ong Vallibhakara S, et al. Prevalence of polycystic ovary syndrome in Thai university adolescents. Gynecol Endocrinol. 2018;34(6):476–480.
  • Nidhi R, Padmalatha V, Nagarathna R, et al. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011; 24(4):223–227. doi: 10.1016/j.jpag.2011.03.002.
  • Balaji S, Amadi C, Prasad S, et al. Urban rural comparisons of polycystic ovary syndrome burden among adolescent girls in a hospital setting in India. Biomed Res Int. 2015;2015:158951.
  • Sıklar Z, Berberoğlu M, Çamtosun E, et al. Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence. J Pediatr Adolesc Gynecol. 2015;28(2):78–83. doi: 10.1016/j.jpag.2014.05.006.
  • Hickey M, Doherty DA, Atkinson H, et al. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Human Rep. 2011;26(6):1469–1477. doi: 10.1093/humrep/der102.
  • Kumari S, Pankaj S, Kavita K, et al. Study of adolescent girls with menstrual irregularities for polycystic ovaries and insulin resistance. Jemds. 2015;4(32):5472–5483. doi: 10.14260/jemds/2015/802.
  • Fruzzetti F, Baldari F, Palla G, et al. Comparison of PCOS phenotypes in adolescent and young adult mediterranean women with possible PCOS. J Endocrinol Invest. 2021;44(5):995–1000. doi: 10.1007/s40618-020-01394-3.
  • Rehme MFB, Pontes AG, Goldberg TBL, et al. Manifestações clínicas, bioquímicas, ultrassonográficas e metabólicas da síndrome dos ovários policísticos em adolescentes [Clinical manifestations, biochemical, ultrasonographic and metabolic of polycystic ovary syndrome in adolescents]. Rev Bras Ginecol Obstet. 2013;35(6):249–254. doi: 10.1590/s0100-72032013000600003.
  • Macklon NS, Fauser BCJM. Aspects of ovarian follicle development throughout life. Horm Res. 1999;52:161–170.
  • Guzick D. Polycystic ovary syndrome: symptomatology, pathophysiology, and epidemiology. Am J Obstet Gynecol. 1998;179(6 Pt 2):S89–S93. doi: 10.1016/s0002-9378(98)70238-8.
  • Tay CT, Hart RJ, Hickey M, et al. Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood. BMC Med. 2020;18(1):389. doi: 10.1186/s12916-020-01861-x.
  • Guney G, Taskin MI, Baykan O, et al. Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study. Ther Adv Endocrinol Metab. 2021;12:20420188211049607. doi: 10.1177/20420188211049607.
  • Camili FE, Akis M, Adali E, et al. Oncostatin M is related to polycystic ovary syndrome-case control study. Biomedicines. 2024;12(2):355. doi: 10.3390/biomedicines12020355.
  • Hausman GJ, Barb CR. Adipose tissue and the reproductive axis: biological aspects. Endocr Dev. 2010;19:31–44. doi: 10.1159/000316895.
  • Bliss SP, Navratil AM, Xie J, et al. ERK signaling, but not c-Raf, is required for gonadotropin-releasing hormone (GnRH)-induced regulation of Nur77 in pituitary gonadotropes. Endocrinology. 2012;153(2):700–711. doi: 10.1210/en.2011-0247.
  • Guney G, Taşkın MI, Sener N, et al. The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis. Reprod Biol Endocrinol. 2022;20(1):95. doi: 10.1186/s12958-022-00967-6.
  • Vitalle MSS, Tomioka CY, Juliano Y, et al. Índice de massa corporal, desenvolvimento puberal e sua relação com a menarca. Rev Assoc Med Bras. 2003;49(4):429–433. doi: 10.1590/S0104-42302003000400036.
  • Roberts SA, Kaiser UB. Genetics in endocrinology: genetic etiologies of Central precocious puberty and the role of imprinted genes. Eur J Endocrinol. 2020;183(4):R107–R117. doi: 10.1530/EJE-20-0103.
  • Barber TM, McCarthy MI, Wass JA, et al. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2006;65(2):137–145. doi: 10.1111/j.1365-2265.2006.02587.x.
  • Legro RS. The genetics of obesity. Lessons for polycystic ovary syndrome. Ann N Y Acad Sci. 2000;900:193–202. doi: 10.1111/j.1749-6632.2000.tb06230.x.
  • Balen AH, Conway GS, Kaltsas G, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10(8):2107–2111. doi: 10.1093/oxfordjournals.humrep.a136243.
  • Lim SS, Davies MJ, Norman RJ, et al. Overweight, obesity and Central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618–637. doi: 10.1093/humupd/dms030.
  • Faria FR, Gusmão LS, Faria ER, et al. Síndrome do ovário policístico e fatores relacionados em adolescentes de 15 a 18 anos. Revista da Associação Médica Brasileira. 2013;59(4):341–346. doi: 10.1016/j.ramb.2013.02.003.
  • Barber TM, Hanson P, Weickert MO, et al. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042. doi: 10.1177/1179558119874042.
  • Fu L, Qu F, Pan J, et al. Polycystic ovary syndrome in adolescents with obesity. Rev Assoc Med Bras (1992). 2021;67(3):468–473. doi: 10.1590/1806-9282.20200890.